Preclinical Studies Of Mesenchymal Stem Cell (MSC) Administration In Chronic Obstructive Pulmonary Disease (COPD)

The US Leader is NOW in Mexico. It was reported that animal recipients of allogenic MSCs tolerated well of these cells administered by injection ( 36 , 37 ). The umbilical cord-derived mesenchymal stem cells (UC-MSCs) were cultured and expanded using the UC-SCI technology developed by the Stem Cell Institute, VNUHCM University of Science, Ho Chi Minh City, Viet Nam.

At the time of this writing (April 2019) it appears that stem cell therapy can be safely performed, although the long-term side effects remain unknown. Although your lungs possess their own population of healing adult stem cells, there are simply not enough cells present to keep up with the degree of ongoing lung tissue damage which occurs in COPD.

Also growth factors liberated by the stem cells may stimulate the formation of new capillaries (the smallest blood vessels) in the lung leading to tissue repair and better function. Remember my COPD is not from smoking but allergic asthma and chronic inflammation.

Stem Cell Mexico is a team of board-certified specialist led by our chief medical director Cesar Amescua, an experienced and recognized stem cell treatment specialist, anesthesiologist and pain medicine expert with over 30 years stem cell therapy for lungs of practicing experience.

In a recent paper, published in the Journal of Allergy and Clinical Immunology, a team led by Dr Pank Bhavsar and Professor Fan Chung, from Imperial's National Heart and Lung Institute, investigated the effect of cigarette smoke on smooth muscle cells taken from human lungs.

If the patient sees an improvement in their pulmonary function test we highly recommend a second treatment within 6 months of the first. Mesenchymal stem cells alleviate airway inflammation and emphysema in COPD through down-regulation of cyclooxygenase-2 via p38 and ERK MAPK pathways.